Key warning signs requiring urgent evaluation include: Postmenopausal bleeding (any vaginal bleeding occurring more than 12 months after the last menstrual period) Bleeding accompanied by fever, unusual vaginal discharge, or pelvic pain suggesting infection Bleeding associated with pregnancy or suspected pregnancy Recurrent spotting that persists for more than two to three menstrual cycles Patients taking tirzepatide who develop abnormal bleeding should undergo a comprehensive gynecological assessment, including detailed menstrual history, pelvic examination, and pregnancy testing for all reproductive-age women regardless of contraceptive use
T , s gip bn t tin hn khi giao tip vi mi ngi v c th mc c nhng b m mnh yu thch
While pre-cooked, theyre not highly processed in the way frozen dinners or fast food are
Medicare's New $50 Weight Loss Drug Program Starts July 1 but the Fine Print Could Surprise You Starting July 1, 2026, millions of Medicare beneficiaries will have access to weight loss medications like Wegovy and Zepbound for a fixed $50 monthly copay through a new federal demonstration program called the Medicare GLP-1 Bridge
Fatigue is a potential side effect of some weight loss medications
Epidemiology of infertility in China: a population-based study
